Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Bilayered Vocal Fold Tissue Engineering
Beta-Amyloid Protofibrils Cause AD Neuronal Dysfunction
Molecular Mechanisms of Adaptation to Osmotic Stress
Antitumor/Antibiotic Substances - Synthesis and Chemistry
Sugar and Amino Acid Synthesis with Specific Labeling
Recently added grants:
CDC7 kinase in normal and cancer cells: potential implications for cancer treatment
Inhibitors of the G protein GNAS which drives pancreatic tumorigenesis
Defective flow-dependent tubule transport in the pathogenesis of kidney disease
Functional characterization of a novel key regulator of the distal nephron whose deficiency leads to renal fibrosis and cyst formation
Improving Weight Loss in Early Non-responders to Behavioral Treatment
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB67187-3-0-1
Application #
7574868
Study Section
Project Start
2006-09-30
Project End
2009-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/ University of Illinois at Chicago
$344,995
NIH 2007
N01 HL
Sildenafil for Sickle Cell Disease-Associated Pulmonary Hypertension
Schraufnagel, Dean /
$292,732
NIH 2007
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/
Comments
Be the first to comment on this grant
